The global endovenous laser therapy market was valued at USD 313.3 million in 2023. The global endovenous laser therapy market is expected to have a 7.37 % CAGR from 2024 to 2032 and be worth USD 594.16 million by 2032 from USD 336.39 million in 2024.
Endovenous laser therapy is the treatment of eliminating varicose veins using laser energy. The therapy is safe and effective in medical procedures such as eye surgery and dermatology.
According to the American Vein and Lymphatic Society, an estimated 40 million people in the United States suffered from varicose veins in 2019. Furthermore, the growing prevalence of obesity is expected to fuel business growth. In addition, the adoption of emerging technologies resulting from technological innovation and the increasing aging population is expected to fuel the growth rate of the endovenous laser therapy market.
In addition, the growth of the global endovenous laser therapy market is further expected to be supported by increased R&D in ELT (Endovenous laser treatment) and ELA (endovenous laser ablation). Researchers from the Azerbaijan State Advanced Training Institute for Doctors concluded in July 2019 that ELA is a safe, reliable, and less painful method of ablating deficient perforated veins that can be done as an outpatient procedure.
The global endovenous laser therapy market is projected to be hampered by the availability of alternative therapies. The ‘VenaSeal Closure System,’ for instance, is designed to treat varicose veins by sealing the affected vein nearest to the skin (superficial varicose veins). Furthermore, due to its non-sclerosant, non-thermal, and non-tumescent properties, the method eliminates the risk of nerve damage caused by thermal-based procedures. In addition, the market's growth is anticipated to be hampered by high initial costs. Risk factors associated with varicose vein care and a lack of highly skilled professionals restrict the market growth. ELT-related issues are likely to stymie the market expansion. ELT risks include skin burns, deep vein thrombosis, pulmonary embolism, nerve damage, temporary numbness, bruising, phlebitis, hematoma, induration, and a tightness sensation; the challenges faced by the endovenous laser therapy market.
REPORT METRIC |
DETAILS |
Market Size Available |
2023 to 2032 |
Base Year |
2023 |
Forecast Period |
2023 to 2032 |
Segments Covered |
By Technology, End User, and Region |
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges; PESTLE Analysis; Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities |
Regions Covered |
North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa |
Based on technology, the endovenous laser system is expected to lead the global market during the forecast period. The rapid and efficient procedure offered by endovenous laser therapy to treat varicose veins instead of conventional vein surgery positively impacts the endovenous laser systems market.
Based on the end-user, the hospital segment is forecasted to lead the market during the forecast period owing to the rising scale of the hospitals and an increasing number of patients admitted for treatment.
The North American region is anticipated to play the leading role in the global endovenous laser therapy market during the forecast period. The increasing prevalence of obesity in North America is expected to primarily fuel the growth rate of the North American market in the coming days.
The APAC regional market is predicted to grow at a significant CAGR during the forecast period. In addition, the surge in demand for varicose vein treatment procedures due to the increasing number of patients suffering from varicose veins in China is anticipated to increase the adoption of Endovenous laser systems in China, thereby adding to the market attractiveness of this segment in the country and subsequently in the APEJ region.
The European market accounted for a substantial share of the global market in 2021. Higher availability of technologically advanced products, particularly in emerging economies, is anticipated to drive the Endovenous laser systems market revenue in Western Europe over the forecast mentioned above. In Eastern Europe, Russia is estimated to witness a high growth rate in contrast to other countries because of the government initiatives for medical progress in the country.
A few of the notable players operating in the global endovenous laser therapy market profiled in this report are Alma Lasers Ltd., Alna-Medical system GmbH, LSO Medical, AngioDynamics, Inc., Syneron Medical Ltd, Dornier Medtech GmbH, Wontech Co., Ltd, intros Medical Laser GmbH, Energist Ltd among others.
By Technology
By End User
By Region
Frequently Asked Questions
The global endovenous laser therapy market was worth USD 313 million in 2023.
The global endovenous laser therapy market is anticipated to be growing at a CAGR of 7.37% from 2023 to 2032.
The Asia-Pacific region is predicted to be growing at the fastest CAGR during the forecast period.
Alma Lasers Ltd., Alna-Medical system GmbH, LSO Medical, AngioDynamics, Inc., Syneron Medical Ltd, Dornier Medtech GmbH, Wontech Co., Ltd, intros Medical Laser GmbH, Energist Ltd are some of the notable players in the endovenous laser therapy market.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region